Zinc dependent histone deacetylase inhibitors in cancer therapeutics: Recent update

F Sultana, KL Manasa, SP Shaik… - Current Medicinal …, 2019 - ingentaconnect.com
Background: Histone deacetylases (HDAC) are an important class of enzymes that play a
pivotal role in epigenetic regulation of gene expression that modifies the terminal of core …

Heterocycles‐Containing HDAC Inhibitors Active in Cancer: An Overview of the Last Fifteen Years

A Raucci, C Castiello, A Mai, C Zwergel… - …, 2024 - Wiley Online Library
Cancer is one of the primary causes of mortality worldwide. Despite nowadays are
numerous therapeutic treatments to fight tumor progression, it is still challenging to …

Discovery of a para-Acetoxy-benzyl Ester Prodrug of a Hydroxamate-Based Glutamate Carboxypeptidase II Inhibitor as Oral Therapy for Neuropathic Pain

R Rais, J Vávra, T Tichý, RP Dash… - Journal of medicinal …, 2017 - ACS Publications
4-Carboxy-α-[3-(hydroxyamino)-3-oxopropyl]-benzenepropanoic acid 1 is a potent
hydroxamate-based inhibitor of glutamate carboxypeptidase II. In an attempt to improve its …

QSAR analysis of HDAC6 inhibitors

OV Tinkov, VY Grigorev, LD Grigoreva - Moscow University Chemistry …, 2022 - Springer
Histone deacetylase inhibitors are the most important class of drugs for the treatment of
oncology and other diseases due to their effect on cell growth, differentiation, and apoptosis …

[HTML][HTML] QSAR-анализ ингибиторов HDAC6

ОВ Тиньков, ВЮ Григорьев… - … университета. Серия 2 …, 2023 - cyberleninka.ru
Ингибиторы гистондеацетилаз-важнейший класс лекарственных средств для лечения
онкологических и других заболеваний из-за их влияния на рост, дифференцировку и …

ВЕСТНИК МОСКОВСКОГО УНИВЕРСИТЕТА. СЕРИЯ 2: ХИМИЯ

ВИ ТИШКОВ, АА ПОМЕТУН, СС САВИН - ВЕСТНИК МОСКОВСКОГО …, 2023 - elibrary.ru
NAD (P)+-зависимая формиатдегидрогеназа (КФ 1.2. 1.2, FDH) катализирует простую с
точки зрения химии и биологии реакцию окисления формиат-иона до углекислого газа …